Influence of left bundle branch block on long-term mortality in a population with heart failure

Fariborz Tabrizi1, Anders Englund, Mårten Rosenqvist

  • 1Department of Cardiology, Karolinska University Hospital, Karolinska Institutet, S-141 86 Stockholm, Sweden. fariborz.tabrizi@karolinska.se

European Heart Journal
|August 3, 2007
PubMed

Insights

Left bundle branch block (LBBB) is common in heart failure (HF) patients and linked to high mortality. However, LBBB itself does not independently increase long-term mortality; comorbidities and heart dysfunction are the primary drivers.

Area of Science:

  • Cardiology
  • Clinical Research
  • Public Health

Background:

  • Left bundle branch block (LBBB) is frequently observed in patients with symptomatic heart failure (HF).
  • The independent prognostic value of LBBB in HF patients requiring hospitalization remains a subject of investigation.
  • Understanding the specific contribution of LBBB to mortality is crucial for risk stratification and management.

Purpose of the Study:

  • To determine the independent impact of LBBB on long-term mortality in a large cohort of symptomatic HF patients.
  • To differentiate the effect of LBBB from confounding factors like comorbidities and myocardial function.

Main Methods:

  • Prospective cohort study of 21,685 symptomatic HF admissions from the Swedish Heart Intensive care Admissions Register (1995-2003).
  • Logistic regression analysis was used to evaluate long-term mortality, adjusting for multiple covariates.
  • Subgroup analyses were performed, including and excluding left ventricular ejection fraction.

Main Results:

  • LBBB was present in 20% of HF admissions and associated with a higher prevalence of cardiac comorbidities.
  • Unadjusted analyses showed higher 1-, 5-, and 10-year mortality in HF patients with LBBB.
  • After adjusting for comorbidities, LBBB was linked to increased 5-year mortality (OR, 1.21).
  • However, when left ventricular ejection fraction was included, LBBB lost its independent association with 5-year mortality (OR, 0.99).

Conclusions:

  • LBBB is prevalent in hospitalized HF patients and associated with high mortality.
  • The increased long-term mortality in HF patients with LBBB appears primarily driven by underlying cardiac comorbidities and myocardial dysfunction, not LBBB itself.
  • LBBB may serve as a marker for more severe cardiac disease rather than an independent predictor of mortality.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...